Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimation of "safe doses" in carcinogenic experiments

H O Hartley, R L Sielken

    Biometrics
    |March 1, 1977
    PubMed
    Summary

    This study introduces a new statistical method for estimating safe doses in carcinogenicity testing. The data-driven approach objectively determines safe levels, accommodating various experimental designs and improving accuracy with increased experimental effort.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Note on the calculation of the distribution of the estimate of mean deviation in normal samples.

    Biometrika·2010
    Same author

    Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.

    Risk analysis : an official publication of the Society for Risk Analysis·2004
    Same author

    Observed versus predicted carboxyhemoglobin levels in cellulose triacetate workers exposed to methylene chloride.

    American journal of industrial medicine·2001
    Same author

    Dose-response implications of the University of Alabama study of lymphohematopoietic cancer among workers exposed to 1,3-butadiene and styrene in the synthetic rubber industry.

    Chemico-biological interactions·2001
    Same author

    Are calories responsible for a decline in longevity?

    Human & experimental toxicology·2000
    Same author

    Risk metrics and cumulative risk assessment methodology for the FQPA.

    Regulatory toxicology and pharmacology : RTP·2000

    Area of Science:

    • Toxicology
    • Biostatistics
    • Risk Assessment

    Background:

    • Carcinogenic safety testing requires objective methods for estimating safe dose levels.
    • Current methods may rely on assumptions about dose-response relationships.
    • Accurate estimation of safe doses is crucial for regulatory decisions by agencies like the Food and Drug Administration (FDA).

    Purpose of the Study:

    • To develop and present a novel statistical methodology for carcinogenic safety testing.
    • To provide an objective, data-based approach for estimating "safe" doses.
    • To create a flexible model applicable to diverse experimental data and risk assessments.

    Main Methods:

    • Utilizes a parametric model for age-specific hazard rates, accommodating experimental variations.
    • Employs maximum likelihood estimation with convex programming for sophisticated and efficient analysis.
    • The methodology integrates analysis for tumor incidence rates, times to tumor, or a mix of both.

    Main Results:

    • The developed method objectively estimates safe doses without assuming minimum slopes in dose-response relationships.
    • It allows for flexibility in accommodating carcinogen, species, and experimental protocol differences.
    • Increased experimental effort leads to higher lower confidence limits for safe doses, approaching true values.

    Conclusions:

    • The proposed statistical methodology offers an objective, data-driven approach to carcinogenic safety testing.
    • The model's flexibility and computational efficiency enhance its applicability.
    • Recommendations include prioritizing time-to-tumor data and increasing the number of dose levels for improved accuracy.

    Related Experiment Videos